Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives.

Ulf M E Wikesjö, Giuseppe Polimeni, Mohammed Qahash

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Surgical placement of oral implants is governed by the prosthetic design and by the morphology and quality of the alveolar bone. Nevertheless implant placement often appears difficult, if at all possible, due to aberrations of the alveolar ridge. Hence prosthetically dictated implant positioning often entails augmentation of the alveolar ridge and adjoining structures. In this review we discuss recent observations of the biologic potential, clinical relevance, and perspectives of application of recombinant human bone morphogenetic protein-2 (rhBMP-2) technologies for alveolar bone augmentation and oral implant osseointegration. Using discriminating critical-size supraalveolar defects and clinical modeling in dogs, we show that rhBMP-2 has a substantial potential for augmenting alveolar bone and supporting osseointegration of titanium oral implants. Moreover, using clinical modeling, we demonstrate re-osseointegration in advanced periimplantitis defects and long-term functional loading of titanium oral implants placed into rhBMP-2-induced bone. Our studies suggest that inclusion of rhBMP-2 for alveolar bone augmentation and oral implant fixation will not only enhance the predictability of existing clinical protocol but also allow new approaches to these procedures.

Original languageEnglish (US)
Pages (from-to)112-119
Number of pages8
JournalClinical Implant Dentistry and Related Research
Volume7
Issue number2
DOIs
StatePublished - Jan 1 2005

Fingerprint

Experimental Implants
Osseointegration
Tissue Engineering
Bone and Bones
Titanium
Alveolar Ridge Augmentation
Peri-Implantitis
Alveolar Process
Clinical Protocols
recombinant human bone morphogenetic protein-2
Dogs
Technology

ASJC Scopus subject areas

  • Oral Surgery
  • Dentistry(all)

Cite this

Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration : experimental observations and clinical perspectives. / Wikesjö, Ulf M E; Polimeni, Giuseppe; Qahash, Mohammed.

In: Clinical Implant Dentistry and Related Research, Vol. 7, No. 2, 01.01.2005, p. 112-119.

Research output: Contribution to journalReview article

@article{31404f4f46f64c26ad5b2a6de79c05f5,
title = "Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives.",
abstract = "Surgical placement of oral implants is governed by the prosthetic design and by the morphology and quality of the alveolar bone. Nevertheless implant placement often appears difficult, if at all possible, due to aberrations of the alveolar ridge. Hence prosthetically dictated implant positioning often entails augmentation of the alveolar ridge and adjoining structures. In this review we discuss recent observations of the biologic potential, clinical relevance, and perspectives of application of recombinant human bone morphogenetic protein-2 (rhBMP-2) technologies for alveolar bone augmentation and oral implant osseointegration. Using discriminating critical-size supraalveolar defects and clinical modeling in dogs, we show that rhBMP-2 has a substantial potential for augmenting alveolar bone and supporting osseointegration of titanium oral implants. Moreover, using clinical modeling, we demonstrate re-osseointegration in advanced periimplantitis defects and long-term functional loading of titanium oral implants placed into rhBMP-2-induced bone. Our studies suggest that inclusion of rhBMP-2 for alveolar bone augmentation and oral implant fixation will not only enhance the predictability of existing clinical protocol but also allow new approaches to these procedures.",
author = "Wikesj{\"o}, {Ulf M E} and Giuseppe Polimeni and Mohammed Qahash",
year = "2005",
month = "1",
day = "1",
doi = "10.1111/j.1708-8208.2005.tb00054.x",
language = "English (US)",
volume = "7",
pages = "112--119",
journal = "Clinical Implant Dentistry and Related Research",
issn = "1523-0899",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration

T2 - experimental observations and clinical perspectives.

AU - Wikesjö, Ulf M E

AU - Polimeni, Giuseppe

AU - Qahash, Mohammed

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Surgical placement of oral implants is governed by the prosthetic design and by the morphology and quality of the alveolar bone. Nevertheless implant placement often appears difficult, if at all possible, due to aberrations of the alveolar ridge. Hence prosthetically dictated implant positioning often entails augmentation of the alveolar ridge and adjoining structures. In this review we discuss recent observations of the biologic potential, clinical relevance, and perspectives of application of recombinant human bone morphogenetic protein-2 (rhBMP-2) technologies for alveolar bone augmentation and oral implant osseointegration. Using discriminating critical-size supraalveolar defects and clinical modeling in dogs, we show that rhBMP-2 has a substantial potential for augmenting alveolar bone and supporting osseointegration of titanium oral implants. Moreover, using clinical modeling, we demonstrate re-osseointegration in advanced periimplantitis defects and long-term functional loading of titanium oral implants placed into rhBMP-2-induced bone. Our studies suggest that inclusion of rhBMP-2 for alveolar bone augmentation and oral implant fixation will not only enhance the predictability of existing clinical protocol but also allow new approaches to these procedures.

AB - Surgical placement of oral implants is governed by the prosthetic design and by the morphology and quality of the alveolar bone. Nevertheless implant placement often appears difficult, if at all possible, due to aberrations of the alveolar ridge. Hence prosthetically dictated implant positioning often entails augmentation of the alveolar ridge and adjoining structures. In this review we discuss recent observations of the biologic potential, clinical relevance, and perspectives of application of recombinant human bone morphogenetic protein-2 (rhBMP-2) technologies for alveolar bone augmentation and oral implant osseointegration. Using discriminating critical-size supraalveolar defects and clinical modeling in dogs, we show that rhBMP-2 has a substantial potential for augmenting alveolar bone and supporting osseointegration of titanium oral implants. Moreover, using clinical modeling, we demonstrate re-osseointegration in advanced periimplantitis defects and long-term functional loading of titanium oral implants placed into rhBMP-2-induced bone. Our studies suggest that inclusion of rhBMP-2 for alveolar bone augmentation and oral implant fixation will not only enhance the predictability of existing clinical protocol but also allow new approaches to these procedures.

UR - http://www.scopus.com/inward/record.url?scp=22344443685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22344443685&partnerID=8YFLogxK

U2 - 10.1111/j.1708-8208.2005.tb00054.x

DO - 10.1111/j.1708-8208.2005.tb00054.x

M3 - Review article

C2 - 15996358

AN - SCOPUS:22344443685

VL - 7

SP - 112

EP - 119

JO - Clinical Implant Dentistry and Related Research

JF - Clinical Implant Dentistry and Related Research

SN - 1523-0899

IS - 2

ER -